416 related articles for article (PubMed ID: 32000067)
1. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial.
Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G;
Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067
[TBL] [Abstract][Full Text] [Related]
2. The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trial.
Böhm F; Mogensen B; Östlund O; Engstrøm T; Fossum E; Stankovic G; Angerås O; Ērglis A; Menon M; Schultz C; Berry C; Liebetrau C; Laine M; Held C; Rück A; James SK
Am Heart J; 2021 Nov; 241():92-100. PubMed ID: 34310907
[TBL] [Abstract][Full Text] [Related]
3. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction.
Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; De Bruyne B; Chatellier G; Danchin N;
N Engl J Med; 2021 Jul; 385(4):297-308. PubMed ID: 33999545
[TBL] [Abstract][Full Text] [Related]
4. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
[TBL] [Abstract][Full Text] [Related]
5. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial.
Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E
Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease.
Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF
Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784
[TBL] [Abstract][Full Text] [Related]
7. Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis.
Archilletti F; Ricci F; Pelliccia F; Dangas G; Giuliani L; Radico F; Perfetti M; Rossi S; Gallina S; Maddestra N; Khanji MY; Zimarino M
Int J Cardiol; 2023 Jan; 370():122-128. PubMed ID: 36328114
[TBL] [Abstract][Full Text] [Related]
8. Design and rationale of the COMPARE-ACUTE trial: Fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease.
Smits PC; Assaf A; Richardt G; Omerovic E; Abdel-Wahab M; Neumann FJ
Am Heart J; 2017 Apr; 186():21-28. PubMed ID: 28454829
[TBL] [Abstract][Full Text] [Related]
9. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
[TBL] [Abstract][Full Text] [Related]
10. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.
Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM;
JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954
[TBL] [Abstract][Full Text] [Related]
11. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y;
Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031
[TBL] [Abstract][Full Text] [Related]
12. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction.
Böhm F; Mogensen B; Engstrøm T; Stankovic G; Srdanovic I; Lønborg J; Zwackman S; Hamid M; Kellerth T; Lauermann J; Kajander OA; Andersson J; Linder R; Angerås O; Renlund H; Ērglis A; Menon M; Schultz C; Laine M; Held C; Rück A; Östlund O; James S;
N Engl J Med; 2024 Apr; 390(16):1481-1492. PubMed ID: 38587995
[TBL] [Abstract][Full Text] [Related]
13. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial.
Lee JM; Kim HK; Park KH; Choo EH; Kim CJ; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY;
Eur Heart J; 2023 Feb; 44(6):473-484. PubMed ID: 36540034
[TBL] [Abstract][Full Text] [Related]
14. Three-Year Outcomes With Fractional Flow Reserve-Guided or Angiography-Guided Multivessel Percutaneous Coronary Intervention for Myocardial Infarction.
Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; Ngaleu Siaha F; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; Djadi-Prat J; Chatellier G; Danchin N;
Circ Cardiovasc Interv; 2024 Jun; 17(6):e013913. PubMed ID: 38785084
[TBL] [Abstract][Full Text] [Related]
15. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR
JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651
[TBL] [Abstract][Full Text] [Related]
16. Fractional flow reserve-guided complete revascularization versus culprit-only revascularization in acute ST-segment elevation myocardial infarction and multi-vessel disease patients: a meta-analysis and systematic review.
Wang LJ; Han S; Zhang XH; Jin YZ
BMC Cardiovasc Disord; 2019 Mar; 19(1):49. PubMed ID: 30823897
[TBL] [Abstract][Full Text] [Related]
17. Design and rationale of the COMPLETE trial: A randomized, comparative effectiveness study of complete versus culprit-only percutaneous coronary intervention to treat multivessel coronary artery disease in patients presenting with ST-segment elevation myocardial infarction.
Mehta SR; Wood DA; Meeks B; Storey RF; Mehran R; Bainey KR; Nguyen H; Bangdiwala SI; Cairns JA;
Am Heart J; 2019 Sep; 215():157-166. PubMed ID: 31326681
[TBL] [Abstract][Full Text] [Related]
18. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial.
Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L;
Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918
[TBL] [Abstract][Full Text] [Related]
19. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of fractional flow reserve guided complete revascularization versus infarct related artery only revascularization in patients with ST-elevation myocardial infarction and multivessel coronary artery disease.
Neupane S; Singh H; Edla S; Altujjar M; Yamsaki H; Lalonde T; Rosman HS; Eggebrecht H; Mehta RH
Coron Artery Dis; 2019 Sep; 30(6):393-397. PubMed ID: 31094897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
